# Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

> clinical trial · VERIFIED · 2026-07-09

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

- Company: AstraZeneca
- Sector: Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
- Primary source: https://clinicaltrials.gov/study/NCT07509151

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.